We just received data on a new analyst forecast for $CYTK. Paul Choi from Goldman Sachs set a price target of 95.0 for CYTK.
To track analyst ratings and price targets for $CYTK, check out Quiver Quantitative's $CYTK forecast page.
Should you buy $CYTK?
Some analysts are better than others. To view the past performance of Goldman Sachs, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CYTK Price Targets
Multiple analysts have issued price targets for $CYTK recently. We have seen 11 analysts offer price targets for $CYTK in the last 6 months, with a median target of $84.0.
Here are some recent targets:
- Paul Choi from Goldman Sachs set a target price of $95.0 on 12/19/2025
- Serge Belanger from Needham set a target price of $72.0 on 12/12/2025
- Leonid Timashev from RBC Capital set a target price of $87.0 on 11/11/2025
- Mayank Mamtani from B. Riley Securities set a target price of $90.0 on 11/10/2025
- Gena Wang from Barclays set a target price of $82.0 on 10/06/2025
- Jason Zemansky from B of A Securities set a target price of $56.0 on 10/02/2025
- Joseph Pantginis from HC Wainwright & Co. set a target price of $120.0 on 09/29/2025
$CYTK Insider Trading Activity
$CYTK insiders have traded $CYTK stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $CYTK stock by insiders over the last 6 months:
- ANDREW CALLOS (EVP, Chief Commercial Officer) has made 0 purchases and 2 sales selling 53,528 shares for an estimated $3,530,182.
- EDWARD M. MD KAYE has made 0 purchases and 5 sales selling 53,447 shares for an estimated $3,321,199.
- ROBERT I BLUM (President & CEO) has made 0 purchases and 9 sales selling 45,000 shares for an estimated $2,115,200.
- FADY IBRAHAM MALIK (EVP Research & Development) has made 0 purchases and 12 sales selling 25,000 shares for an estimated $1,294,716.
- JOHN T HENDERSON sold 8,750 shares for an estimated $559,125
- B LYNNE PARSHALL sold 5,000 shares for an estimated $323,650
- WENDELL WIERENGA sold 4,375 shares for an estimated $256,725
- ROBERT ARTHUR HARRINGTON has made 0 purchases and 2 sales selling 4,300 shares for an estimated $248,260.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CYTK Congressional Stock Trading
Members of Congress have traded $CYTK stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CYTK stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 10/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CYTK Hedge Fund Activity
We have seen 228 institutional investors add shares of $CYTK stock to their portfolio, and 175 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VESTAL POINT CAPITAL, LP removed 2,250,000 shares (-75.6%) from their portfolio in Q3 2025, for an estimated $123,660,000
- FMR LLC added 1,824,136 shares (+16.2%) to their portfolio in Q3 2025, for an estimated $100,254,514
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,478,056 shares (+8.4%) to their portfolio in Q3 2025, for an estimated $81,233,957
- WOODLINE PARTNERS LP added 1,435,422 shares (+676.1%) to their portfolio in Q3 2025, for an estimated $78,890,793
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,310,336 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $43,293,501
- UBS GROUP AG removed 1,267,414 shares (-41.3%) from their portfolio in Q3 2025, for an estimated $69,657,073
- HOOD RIVER CAPITAL MANAGEMENT LLC removed 1,256,580 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $41,517,403
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
